A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers.
about
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosisCurrent Therapeutic Cannabis Controversies and Clinical Trial Design IssuesDelta-9-tetrahydrocannabinol/cannabidiol (Sativex®): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.Dronabinol and chronic pain: importance of mechanistic considerations.Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity.High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana.Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy.Cannabis sativa (Hemp) Seeds, Δ9-Tetrahydrocannabinol, and Potential Overdose.Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
P2860
Q26770823-0F526887-D670-428F-AA2E-A57529C4728AQ28071794-F5DB9E47-8567-4B91-B3CE-6EACDF2E83ECQ38199658-C787AD67-A1D6-4876-AA48-F921FA53160AQ38211191-29B728FD-2387-4282-AB99-FCD4EFBC8078Q38261541-8B4FF0CA-36D4-45D4-BE43-17F78209F65BQ38681635-2182B330-C50B-4B8F-8E7B-04E5EC8C2C04Q38815352-9C470751-2CD2-4299-8F55-7CE614370E92Q39178828-00CA53F4-F8DE-4763-84D1-EDF5D593C269Q41434713-6E7A37E1-A467-46DC-9890-530CAED78C4CQ41560648-B3C71043-DCFA-4932-BCF9-2F891A7987A4Q46073970-46DFF375-2527-4F1F-8E1A-EDFE97BA2130Q47643955-3DCA6C3C-3248-4ADB-8661-24C325FF227A
P2860
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A Phase I, open-label, randomi ...... l spray in healthy volunteers.
@en
type
label
A Phase I, open-label, randomi ...... l spray in healthy volunteers.
@en
prefLabel
A Phase I, open-label, randomi ...... l spray in healthy volunteers.
@en
P2093
P2860
P356
P1433
P1476
A Phase I, open-label, randomi ...... l spray in healthy volunteers.
@en
P2093
Colin Stott
Darren Wilbraham
Geoffrey Guy
Linda White
Stephen Wright
P2860
P2888
P356
10.1186/2193-1801-2-236
P577
2013-05-24T00:00:00Z
P5875
P6179
1016114344